Dose Escalation/Dose Expansion Study of YBL-006 in Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04450901

Recruitment Status : Not yet recruiting

First Posted : June 30, 2020

Last Update Posted : June 30, 2020

See Contacts and Locations

Sponsor:

Collaborator:

Novotech (Australia) Pty Limited

Information provided by (Responsible Party):

Y Biologics Inc.

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Not yet recruiting
Estimated Primary Completion Date :	September 30, 2022
Estimated Study Completion Date :	September 30, 2022

To Top